Our findings reveal a novel mechanism by which HIF-1α modulates pancreatic cancer ECM via the TGF-β1/Smad axis, offering potential therapeutic strategies to target the dense stromal component of this malignancy. This evidence concerns the gene TGFB1 and pancreatic neoplasm.